Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis
Top Cited Papers
- 17 February 2006
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 59 (3), 499-503
- https://doi.org/10.1002/ana.20820
Abstract
Objective To characterize the association between infectious mononucleosis (IM), a frequent clinical manifestation of primary Epstein–Barr virus infection after childhood, and the risk for multiple sclerosis (MS). Methods We conducted a systematic review and meta‐analysis of case–control and cohort studies of IM and MS. Results The combined relative risk of MS after IM from 14 studies was 2.3 (95% confidence interval, 1.7–3.0; p < 10−8). Potential sources of heterogeneity (ie, study design, MS definition, and latitude) barely influenced our results. Interpretation We conclude that Epstein–Barr virus infection manifesting as IM in adolescents and young adults is a risk factor for MS. Ann Neurol 2006; 59:499–503Keywords
This publication has 31 references indexed in Scilit:
- A case-control epidemiological study of MS in the Paris area with particular reference to past disease history and professionActa Neurologica Scandinavica, 2009
- Multiple sclerosis after infectious mononucleosis: record linkage studyJournal of Epidemiology and Community Health, 2004
- Risk factors of multiple sclerosis: a case-control studyNeurological Sciences, 2003
- A functional and structural basis for TCR cross-reactivity in multiple sclerosisNature Immunology, 2002
- The Danish Multiple Sclerosis Registry: a 50-year follow-upMultiple Sclerosis Journal, 1999
- Environmental risk factors in MS: a case-control study in MoscowActa Neurologica Scandinavica, 1996
- Environmental Risk Factors and Multiple Sclerosis: A Community-Based, Case-Control Study in the Province of Ferrara, ItalyNeuroepidemiology, 1994
- Multiple Sclerosis in Galion, Ohio: Prevalence and Results of a Case-Control StudyNeuroepidemiology, 1991
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986